Urogen Pharma Ltd. (URGN)
Market Closed
1 Sep, 20:00
$
43. 39
+0.3
+0.6962%
After Hours
$
+2.47 +5.6926% 45. 86
2.1B Market Cap
- P/E Ratio
- Div Yield
584,181 Volume
-3.56 Eps
$ 43.09
Previous Close 
Want to track URGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Urogen Pharma Ltd. (URGN) Statistics
Valuation metrics
Market Cap 2.1B
Enterprise value 2.24B
Trailing P/E (ttm) -22.03
Forward P/E 20.03
PEG ratio -0.44
Price/Sales (ttm) 11.26
Price/Book (mrq) -16.6
Enterprise Value/Revenue 11.88
Enterprise Value/EBITDA -31.71
Overview
Shares outstanding 48.35M
Float 38.71M
Shares short 7.24M
% Held by insiders 0.04%
% Held by institutions 0.98%
Average volume (10 days) 851.22K
Average volume (90 days) 851.58K
Price summary
52-Week low 15.86
52-Week high 50.81
Beta 1.59
50-Day moving average 42.73
200-Day moving average 25.42
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.52%
Operating margin -0.35%
Operational effectiveness
Return on assets -0.39%
Return on equity 0.82%
Income Statement
Revenue (ttm) 140.49M
Revenue per share (ttm) 3.75
Quarterly revenue growth (yoy) 1.52%
Gross profit (ttm) 126.24M
EBITDA -107.9M
Net income to common (ttm) -133.22M
Diluted EPS (ttm) -1.94
Quarterly earnings growth (yoy) 0.54%
Balance Sheet
Total cash (mrq) 140.27M
Total cash per share (mrq) 2.14
Total debt (mrq) 197.09M
Total Debt/Equity (mrq) -1.48
Current ratio (mrq) 3.8%
Book value per share (mrq) -2.63
Cash Flow
Cash flow statement -165.74M
Levered free cash flow (LFCF) -109.28M
